[
    [
        {
            "time": "",
            "original_text": "医药生物行业周报：机会可以是跌出来的",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "行业周报",
                    "机会",
                    "跌出来"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报：机会可以是跌出来的",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02",
            "original_text": "[买入评级]2018年2月份医药行业投资策略：医药板块中期走强趋势不变，迎战略性加仓机会",
            "features": {
                "keywords": [
                    "买入评级",
                    "医药",
                    "投资策略",
                    "中期走强",
                    "加仓机会"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]2018年2月份医药行业投资策略：医药板块中期走强趋势不变，迎战略性加仓机会",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]长春高新(000661)年报点评：生长激素引领业绩高增长，龙头地位持续稳固",
            "features": {
                "keywords": [
                    "买入评级",
                    "长春高新",
                    "年报",
                    "生长激素",
                    "业绩高增长",
                    "龙头地位"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入评级]长春高新(000661)年报点评：生长激素引领业绩高增长，龙头地位持续稳固",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2017",
            "original_text": "【华创医药】长春高新(000661.SZ)2017年年报点评：生物类药品快速增长，业绩符合预期",
            "features": {
                "keywords": [
                    "华创医药",
                    "长春高新",
                    "年报",
                    "生物类药品",
                    "快速增长",
                    "业绩符合预期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【华创医药】长春高新(000661.SZ)2017年年报点评：生物类药品快速增长，业绩符合预期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]